Ideal Candidates for Direct Meds Adults with a BMI of 27+ with a weight-related health condition, or BMI of 30+ Patients who cannot afford or access brand-name GLP-1 medications through insurance People in states where Direct Meds USA operates who prefer a fully remote pharmacy experience Patients who have been screened and recommended for semaglutide or tirzepatide by a prior provider Individuals comfortable managing their care through a digital patient portal Who Should Avoid Direct Meds or Proceed with Caution Pregnant or breastfeeding women, GLP-1 medications are contraindicated Anyone under 18 years of age Patients with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN2) Patients with severe pancreatitis history or active pancreatic disease People in states not currently served by Direct Meds of Florida This qualification overview is for general guidance only
The problem with random protocols Common mistake : Starting peptides without clear timeline or goals What happens : Stop too early when results just beginning Continue too long without reassessment Waste money on ineffective short runs Miss optimal transition windows No clear endpoint or success metrics Result : Disappointing outcomes, wasted money, unclear whether peptides "work" Learn about how peptides work to understand timing
Kharfi A, Giguere Y, De Grandpre P, Moutquin JM, Forest JC: Human chorionic gonadotropin (hCG) may be a marker of systemic oxidative stress in normotensive and preeclamptic term pregnancies
Tracing the Anti-Inflammatory Mechanism/Triggers of d-Allulose: A Profile Study of Microbiome Composition and mRNA Expression in Diet-Induced Obese Mice
I've also seen employers add GLP-1 coverage mid-year when employees made a strong case about productivity and healthcare cost savings." 8
.webp)
